ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
TriSalus Life Sciences Inc

TriSalus Life Sciences Inc (TLSI)

4.05
-0.13
(-3.11%)
마감 25 9월 5:00AM
4.05
0.00
( 0.00% )
시간외 단일가: 5:17PM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
4.05
매수가
3.90
매도가
6.02
거래량
-
0.00 일간 변동폭 0.00
3.32 52주 범위 10.42
전일 종가
4.05
개장가
-
최근 거래 시간
마지막 거래 시간
-
평균 볼륨(3m)
46,985
재정 규모
-
VWAP
-

TLSI 최신 뉴스

TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System

Pressure enabled drug deliver (PEDD) method significantly increased penetration of glass microspheres into porcine liver tumors (117%; p=0.004 and 39%; p=0.032) with lobar infusions and selective...

TriSalus Reports Q2 2024 Financial Results and Business Update

Reported revenues of $7.4 million in Q2 2024 and $13.8 million for six months ended June 30, 2024, up 60% and 82%, respectively, compared to prior year periods Reported gross margin of 88% in Q2...

TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call

Call Scheduled for Thursday, August 15, 2024, at 9:00 a.m. ET TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to...

TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation

TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients...

TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants

TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients...

TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 ASCO Annual Meeting

– Hepatic arterial infusion (HAI) of nelitolimod has been well tolerated and associated with encouraging immunologic activity in patients with HCC and ICC – 4 mg dose demonstrated 3 of 3 patients...

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients...

TriSalus Reports Q1 2024 Financial Results and Business Update

Reported revenues of $6.5 million in 1Q24, up 116% compared to 1Q23 Reported gross margin of 85% in 1Q24 Secured up to $50 million of debt financing with OrbiMed to support TriNav® Infusion...

TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors

– Accomplished industry veteran brings deep strategic and operational expertise TriSalus Life Sciences® Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with...

TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call

Call Scheduled for Wednesday, May 15, 2024, at 9:00 a.m. ET TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.5805-12.53644314874.63055.154.05650904.42606902CS
4-1.38-25.41436464095.435.65484.05721084.79887207CS
12-0.95-1956.044.05469855.22099714CS
26-5.69-58.41889117049.7410.424.05457976.87693162CS
52-1.55-27.67857142865.610.423.32501266.99189794CS
156-9.75-70.65217391313.816.243.32505567.01134356CS
260-9.75-70.65217391313.816.243.32505567.01134356CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
OCTOEightco Holdings Inc
US$ 3.88
(55.82%)
5.1M
ELYMEliem Therapeutics Inc
US$ 8.40
(28.05%)
868.14k
MSGMMotorsport Games Inc
US$ 1.38
(25.45%)
4.66M
SEELSeelos Therapeutics Inc
US$ 0.3621
(21.10%)
3.7M
TOIOncology Institute Inc
US$ 0.349
(20.10%)
2
VTNRVertex Energy Inc
US$ 0.159
(-55.96%)
2.58M
BNZIBanzai International Inc
US$ 5.75
(-30.22%)
333.48k
SFIXStitch Fix Inc
US$ 2.71
(-27.73%)
126.34k
PLBYPLBY Group Inc
US$ 0.53
(-26.40%)
74
THTarget Hospitality Corporation
US$ 7.20
(-23.73%)
89.71k
STSSSharps Technology Inc
US$ 0.155
(-9.09%)
12.05M
ELABElevai Labs Inc
US$ 0.1085
(5.34%)
8.11M
OCTOEightco Holdings Inc
US$ 3.88
(55.82%)
5.1M
MSGMMotorsport Games Inc
US$ 1.38
(25.45%)
4.66M
SEELSeelos Therapeutics Inc
US$ 0.3621
(21.10%)
3.7M

최근 히스토리

Delayed Upgrade Clock